FANUY Quote, Financials, Valuation and Earnings

Japan Food Tech Holdings has a net margin of -- compared to Fanuc's net margin of -1471.96%. Fanuc's return on equity of -- beat Japan Food Tech Holdings's return on equity of -241.02%.

Fanuc has a consensus price target of --, signalling downside risk potential of --. On the other hand Japan Food Tech Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that Fanuc has higher upside potential than Japan Food Tech Holdings, analysts believe Fanuc is more attractive than Japan Food Tech Holdings.

Fanuc has a beta of 0.835, which suggesting that the stock is 16.469% less volatile than S&P 500. In comparison Japan Food Tech Holdings has a beta of 45.515, suggesting its more volatile than the S&P 500 by 4451.471%.

Fanuc has a quarterly dividend of $0.15 per share corresponding to a yield of 1.97%. Japan Food Tech Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fanuc pays -- of its earnings as a dividend. Japan Food Tech Holdings pays out -- of its earnings as a dividend.

Fanuc quarterly revenues are --, which are smaller than Japan Food Tech Holdings quarterly revenues of $5.5K. Fanuc's net income of -- is lower than Japan Food Tech Holdings's net income of -$81.3K. Notably, Fanuc's price-to-earnings ratio is -- while Japan Food Tech Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fanuc is 4.37x versus 12.15x for Japan Food Tech Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Kubota has a net margin of -- compared to Fanuc's net margin of 6.75%. Fanuc's return on equity of -- beat Kubota's return on equity of 9.86%.

Fanuc has a consensus price target of --, signalling downside risk potential of --. On the other hand Kubota has an analysts' consensus of -- which suggests that it could grow by 40.55%. Given that Kubota has higher upside potential than Fanuc, analysts believe Kubota is more attractive than Fanuc.

Fanuc has a beta of 0.835, which suggesting that the stock is 16.469% less volatile than S&P 500. In comparison Kubota has a beta of 0.968, suggesting its less volatile than the S&P 500 by 3.175%.

Fanuc has a quarterly dividend of $0.15 per share corresponding to a yield of 1.97%. Kubota offers a yield of 2.8% to investors and pays a quarterly dividend of $0.85 per share. Fanuc pays -- of its earnings as a dividend. Kubota pays out 22.85% of its earnings as a dividend. Kubota's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Fanuc quarterly revenues are --, which are smaller than Kubota quarterly revenues of $4.7B. Fanuc's net income of -- is lower than Kubota's net income of $317.2M. Notably, Fanuc's price-to-earnings ratio is -- while Kubota's PE ratio is 8.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fanuc is 4.37x versus 0.68x for Kubota. Usually stocks with elevated PS ratios are considered overvalued.

Kyocera has a net margin of -- compared to Fanuc's net margin of 7.38%. Fanuc's return on equity of -- beat Kyocera's return on equity of 3.11%.

Fanuc has a consensus price target of --, signalling downside risk potential of --. On the other hand Kyocera has an analysts' consensus of $11.05 which suggests that it could grow by 6.66%. Given that Kyocera has higher upside potential than Fanuc, analysts believe Kyocera is more attractive than Fanuc.

Fanuc has a beta of 0.835, which suggesting that the stock is 16.469% less volatile than S&P 500. In comparison Kyocera has a beta of 0.272, suggesting its less volatile than the S&P 500 by 72.817%.

Fanuc has a quarterly dividend of $0.15 per share corresponding to a yield of 1.97%. Kyocera offers a yield of 3.1% to investors and pays a quarterly dividend of $0.17 per share. Fanuc pays -- of its earnings as a dividend. Kyocera pays out 73.91% of its earnings as a dividend. Kyocera's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Fanuc quarterly revenues are --, which are smaller than Kyocera quarterly revenues of $3.2B. Fanuc's net income of -- is lower than Kyocera's net income of $236M. Notably, Fanuc's price-to-earnings ratio is -- while Kyocera's PE ratio is 20.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fanuc is 4.37x versus 1.07x for Kyocera. Usually stocks with elevated PS ratios are considered overvalued.

SBC Medical Group Holdings has a net margin of -- compared to Fanuc's net margin of 5.34%. Fanuc's return on equity of -- beat SBC Medical Group Holdings's return on equity of 25.89%.

Fanuc has a consensus price target of --, signalling downside risk potential of --. On the other hand SBC Medical Group Holdings has an analysts' consensus of -- which suggests that it could grow by 118.69%. Given that SBC Medical Group Holdings has higher upside potential than Fanuc, analysts believe SBC Medical Group Holdings is more attractive than Fanuc.

Fanuc has a beta of 0.835, which suggesting that the stock is 16.469% less volatile than S&P 500. In comparison SBC Medical Group Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Fanuc has a quarterly dividend of $0.15 per share corresponding to a yield of 1.97%. SBC Medical Group Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fanuc pays -- of its earnings as a dividend. SBC Medical Group Holdings pays out -- of its earnings as a dividend.

Fanuc quarterly revenues are --, which are smaller than SBC Medical Group Holdings quarterly revenues of $53.1M. Fanuc's net income of -- is lower than SBC Medical Group Holdings's net income of $2.8M. Notably, Fanuc's price-to-earnings ratio is -- while SBC Medical Group Holdings's PE ratio is 11.46x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fanuc is 4.37x versus 2.32x for SBC Medical Group Holdings. Usually stocks with elevated PS ratios are considered overvalued.